Immunogenicity and safety of the RTS,S/AS01 malaria vaccine co-administered with measles, rubella and yellow fever vaccines in Ghanaian children: A phase IIIb, multi-center, non-inferiority, randomized, open, controlled trial

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline

This publication has 16 references indexed in Scilit: